Evidence map›Paper›PMID 40136327›Full record

ReviewCurrent oncology (Toronto, Ont.)2025

When "One Size Fits All" Fits None: A Commentary on the Impacts of the"Draft Canadian Breast Cancer Screening Guidelines" on Racialized Populations in Canada.

Beverley Osei, Gayathri Naganathan, Juliet M Daniel, Supriya Kulkarni, Aisha Lofters, Yinka Oladele, Leila Springer, Mojola Omole

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Beverley OseiTemerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0009-0009-2905-1315
Gayathri NaganathanDepartment of Surgery, Michael Garron Hospital, Toronto, ON M4C 3E7 1A1, Canada.ORCID 0000-0003-4334-2740
Juliet M DanielDepartment of Biology, Center for Discovery in Cancer Research, McMaster University, Hamilton, ON L8S 4K1, Canada.ORCID 0000-0002-3497-0772
Supriya KulkarniDepartment of Medical Imaging, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-5120-9248
Aisha LoftersDepartment of Family and Community Medicine, Women's College Hospital, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-7322-0894
Yinka OladeleAfrican Cancer Support Group, Calgary, AB T1Y 6M6, Canada.
Leila SpringerThe Olive Branch of Hope, Toronto, ON M3K 1E6, Canada.
Mojola OmoleDepartment of Surgery, Scarborough Health Network, Scarborough, ON M1P 2T7, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological data show racial and ethnic differences exist in breast cancer morbidity and mortality amongst Black, Indigenous, Asian, and Hispanic populations, with non-white females experiencing earlier age at diagnosis, more aggressive breast cancer subtypes and advanced cancer stages, and earlier mortality than white females. However, the current Canadian breast cancer screening guidelines recommend biannual screening for all females starting from age 50 to age 74 and suggest not to screen individuals aged 40-49. In May 2024, the Canadian Task Force for Preventative Health released updated draft breast cancer screening guidelines, maintaining such recommendations for screening. Both the existing and the proposed guidelines fail to account for the unique cancer burden amongst racialized populations in Canada and risk further perpetuation of existing racial and ethnic disparities by underscreening racialized females. This commentary will present data regarding racial disparities in cancer burden, highlighting the role social and biological factors play in impacting cancer risk and age of disease and presenting perspectives from stakeholder groups reflecting the impacts of current screening guidelines. Ultimately, we critique the current "one-size-fits-all" approach to breast cancer screening in Canada, emphasizing the need for adapted screening practices with the understanding that the current approaches overlook the needs of racialized Canadian populations.

Indexed as

Breast NeoplasmsEarly Detection of CancerAdultCanadaFemaleHumansMiddle AgedPractice Guidelines as Topicbreast cancerequitypublic healthscreening

Identifiers

PMID40136327
PMCPMC11940997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.